Stay updated on Fasinumab vs Placebo & Naproxen in OA Pain Clinical Trial
Sign up to get notified when there's something new on the Fasinumab vs Placebo & Naproxen in OA Pain Clinical Trial page.

Latest updates to the Fasinumab vs Placebo & Naproxen in OA Pain Clinical Trial page
- Check3 days agoChange DetectedA site-wide banner announces an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check10 days agoChange DetectedThe site footer revision marker changes from v3.7.1 to v3.7.2 on the page displaying a 403 Forbidden error.SummaryDifference0.2%

- Check17 days agoChange DetectedThe page remains a 403 Forbidden error page, with the displayed site revision changing from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check31 days agoChange DetectedAccess to the study page now returns a 403 Forbidden error, replacing the full study record content with an error screen. Users cannot view the study details or related sections on this page.SummaryDifference19%

- Check38 days agoChange DetectedRevision updated from v3.6.6 to v3.7.0, signaling a maintenance update to the page or system without altering study content or results.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page now includes an NIH grant/contract entry, '2016 ( U.S. NIH Grant/Contract )', under the Other Study ID Numbers section for NCT03161093. This adds funding/identifier information associated with the trial.SummaryDifference0.0%

Stay in the know with updates to Fasinumab vs Placebo & Naproxen in OA Pain Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fasinumab vs Placebo & Naproxen in OA Pain Clinical Trial page.